Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
By Jamie Gumbrecht, CNN (CNN) — An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow…
Continue Reading